While PCa progression typically depends on androgen receptor (AR) signaling, which makes androgen deprivation therapy (ADT) a cornerstone treatment, SCCP lacks AR expression and is not characterized by abnormal PSA levels; in fact, serum PSA levels often remain normal even during disease progression (17, 31). Here, KLK3 is linked to posterior cortical atrophy.